You have 9 free searches left this month | for more free features.

decitabine,

Showing 376 - 400 of 493

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, Acute Myeloid Leukemia Trial in France (Guadecitabine)

Unknown status
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Angers, France
  • +11 more
Nov 13, 2018

FLT3-ITD Mutation, Acute Myeloid Leukemia, Brutons Tyrosine Kinase Trial in Guangzhou (Ibrutinib)

Enrolling by invitation
  • FLT3-ITD Mutation
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Aug 20, 2018

AML, Relapse Trial in Beijing (Chidamide plus DCAG regimen)

Unknown status
  • AML
  • Relapse
  • Chidamide plus DCAG regimen
  • Beijing, China
    China PLA General Hospital
Feb 12, 2018

Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute

Completed
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 13, 2017

Acute Myeloid Leukemia, Adult Trial (Decitabine, Cytarabine)

Unknown status
  • Acute Myeloid Leukemia, Adult
  • (no location specified)
Dec 3, 2016

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Trial in France, Germany (drug, procedure, other, genetic)

Terminated
  • Myelodysplastic Syndrome (MDS)
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
  • +9 more
Oct 23, 2018

Leukemia, Myeloid, Acute, MDS Trial in St. Louis (LBH589, Decitabine)

Completed
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • St. Louis, Missouri
    Washington University
Aug 18, 2016

Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell

Unknown status
  • Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
  • HMA+DLI
  • DLI
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Sep 5, 2018

Myelodysplastic Syndrome Trial in United States (OPN-305)

Completed
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +3 more
Jan 24, 2019

MDS Trial in Shanghai (CHG regimen, 5-aza-deoxycytidine)

Unknown status
  • Myelodysplastic Syndromes
  • Shanghai, Shanghai, China
    Shanghai 6th People's Hospital
Sep 8, 2016

Sarcoma, Melanoma, Epithelial Malignancies Trial run by the NCI (Epigenetically Modified Autologous Tumor, Cyclophosphamide,

Terminated
  • Sarcoma
  • +3 more
  • Epigenetically Modified Autologous Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing

Unknown status
  • Myelodysplastic Syndrome
  • Chemotherapy
  • Demethylation drug
  • Chemotherapy regimen
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Dec 6, 2017

Recurrent Adult Acute Myeloid Leukemia Trial in Beijing (Deciatbine(DAC))

Unknown status
  • Recurrent Adult Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Aug 29, 2016

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Clofarabine, Cytarabine, Decitabine)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 15, 2016

Acute Myeloid Leukemia Trial in Germany (Decitabine, VPA, ATRA)

Completed
  • Acute Myeloid Leukemia
  • Aachen, Germany
  • +26 more
Aug 30, 2016

Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

Completed
  • Myelodysplastic Syndrome
  • MDS
  • Mobile, Alabama
  • +20 more
Feb 22, 2017

Myelodysplastic Syndrome Trial in United States (decitabine)

Completed
  • Myelodysplastic Syndrome
  • Scottsdale, Arizona
  • +5 more
May 5, 2016

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • Columbus, Ohio
    Ohio State University Medical Center
May 18, 2016

Myelodysplastic Syndrome Trial in New York (Tosedostat)

Completed
  • Myelodysplastic Syndrome
  • New York, New York
    Weill Cornell Medical College
Jun 7, 2018

MDS Trial in Beijing (Microtransplantation)

Completed
  • Myelodysplastic Syndromes
  • Microtransplantation
  • Beijing, Beijing, China
    Affiliated Hospital of Academy of Military Medical Sciences
Jul 12, 2016

Acute Myeloid Leukemia, Myeloproliferative Tumors, MDS Trial in Sao Paulo (Induction Chemotherapy, Consolidation Chemotherapy,

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Induction Chemotherapy
  • +5 more
  • Sao Paulo, SP, Brazil
    Hospital Israelita Albert Einstein
Nov 7, 2016

Myelodysplastic Syndrome Trial in China (Decitabine at 15 mg/m2, Decitabine at 20 mg/m2)

Completed
  • Myelodysplastic Syndrome
  • Decitabine at 15 mg/m2
  • Decitabine at 20 mg/m2
  • Beijing, China
  • +7 more
Apr 1, 2016

MDS Trial in Italy (5-Azacytidine, Valproic Acid, ATRA)

Completed
  • Myelodysplastic Syndromes
  • Arezzo, Italy
  • +6 more
Aug 4, 2018

Immune Thrombocytopenia Trial in Assiut (Hydroxychloroquine, vincristine, azathioprine)

Completed
  • Immune Thrombocytopenia
  • Assiut, Egypt
    Assiut university hospital
Jun 27, 2018